Adagene, Inc. (ADAG)
2.825
-0.10
(-3.58%)
USD |
NASDAQ |
Oct 07, 16:00
2.815
-0.01
(-0.35%)
After-Hours: 20:00
Adagene Price : 2.825 for Oct. 7, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 06, 2026 | 2.82 | 3.02 | 2.82 | 2.93 | 213515.0 |
| Oct 05, 2026 | 2.84 | 2.87 | 2.67 | 2.80 | 325707.0 |
| Oct 02, 2026 | 2.96 | 3.00 | 2.80 | 2.85 | 297967.0 |
| Oct 01, 2026 | 3.12 | 3.12 | 2.915 | 2.93 | 278281.0 |
| Sep 30, 2026 | 3.18 | 3.35 | 3.00 | 3.20 | 254322.0 |
| Sep 29, 2026 | 3.20 | 3.47 | 2.98 | 3.21 | 492589.0 |
| Sep 28, 2026 | 2.94 | 3.21 | 2.87 | 3.20 | 529852.0 |
| Sep 25, 2026 | 2.96 | 3.185 | 2.87 | 2.93 | 197662.0 |
| Sep 24, 2026 | 2.94 | 3.01 | 2.81 | 2.98 | 317092.0 |
| Sep 23, 2026 | 3.16 | 3.22 | 2.92 | 2.97 | 208023.0 |
| Sep 22, 2026 | 3.31 | 3.338 | 3.215 | 3.23 | 226328.0 |
| Sep 21, 2026 | 3.34 | 3.35 | 3.18 | 3.21 | 97781.00 |
| Sep 18, 2026 | 3.37 | 3.505 | 3.171 | 3.31 | 287042.0 |
| Sep 17, 2026 | 3.30 | 3.419 | 3.17 | 3.37 | 261083.0 |
| Sep 16, 2026 | 3.00 | 3.237 | 2.92 | 3.17 | 319282.0 |
| Sep 15, 2026 | 3.385 | 3.385 | 2.925 | 2.97 | 626154.0 |
| Sep 14, 2026 | 3.38 | 3.60 | 3.235 | 3.27 | 155084.0 |
| Sep 11, 2026 | 3.36 | 3.48 | 3.238 | 3.40 | 258867.0 |
| Sep 10, 2026 | 3.54 | 3.552 | 3.20 | 3.31 | 224590.0 |
| Sep 09, 2026 | 3.61 | 3.69 | 3.24 | 3.27 | 267527.0 |
| Sep 08, 2026 | 3.55 | 3.61 | 3.45 | 3.49 | 193001.0 |
| Sep 04, 2026 | 3.67 | 3.692 | 3.56 | 3.58 | 28194.00 |
| Sep 03, 2026 | 3.71 | 3.85 | 3.56 | 3.69 | 167713.0 |
| Sep 02, 2026 | 3.60 | 3.74 | 3.600 | 3.69 | 102670.0 |
| Sep 01, 2026 | 3.51 | 3.675 | 3.42 | 3.64 | 120551.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ascletis Pharma, Inc. | 1.04 |
| CStone Pharmaceuticals Co. Ltd. | 0.7547 |
| RemeGen Co., Ltd. | 9.96 |
| InnoCare Pharma Ltd. | 1.85 |
| JW (Cayman) Therapeutics Co. Ltd. | 0.2022 |
Price Related Metrics
| PS Ratio | 15.77 |
| Earnings Yield | -13.36% |
| Market Cap | 189.68M |